Propanc Biopharma (PPCB) Q4 2026 Earnings Report

82 Followers

PPCB Q4 2026 EPS Results

Actual EPS-$1.38

Consensus EPS―

Beat/Miss―

One Year Ago EPS-$8.77

Actual Revenue$0.00

Expected Revenue―

Beat/Miss―

YoY Revenue Growth―

QuarterQ4 2026

Date09/29/2026

TimeBefore Open

Conference CallTuesday, September 29, 2026

PPCB Upcoming Earnings

Propanc Biopharma's next earnings date is estimated for November 23, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 23, 2026	2027 (Q1)	- / -	-9.808	―
Sep 29, 2026	2026 (Q4)	- / -1.38	-8.766	84.25% (+7.38)
May 15, 2026	2026 (Q3)	- / -7.09	-312.456	97.73% (+305.37)
Feb 18, 2026	2026 (Q2)	- / -7.53	-824.835	99.09% (+817.31)
Nov 17, 2025	2026 (Q1)	- / -9.81	-899.82	98.91% (+890.01)
May 15, 2020	2020 (Q3)	- / -348780.00	-894999.998	61.03% (+546220.00)
Feb 14, 2020	2020 (Q2)	- / -1250780.00	-41335000	96.97% (+40084220.00)
Nov 14, 2019	2019 (Q4)	- / -1414920.00	-9444999.998	85.02% (+8030080.00)
Nov 14, 2019	2020 (Q1)	- / -	-9445	―
May 15, 2019	2019 (Q3)	- / -895.00	-30000	97.02% (+29105.00)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed